CCN2 and ovarian cancer: CTGF has been shown to bind to the fibronectin receptor integrin α5β1 and promote migration in pancreatic cells [34], and integrin α5β1 has been demonstrated to mediate peritoneal adhesion of ovarian cancer cells [35].